This brand name is authorized in Austria, Brazil, Cyprus, Ecuador, Estonia, Hong Kong SAR China, Ireland, Lithuania, Netherlands, New Zealand, Poland, Singapore, South Africa, Tunisia, Turkey.
The drug INFLUVAC contains a combination of these active pharmaceutical ingredients (APIs):
1
|
|
2
|
|
3
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J07BB02 | Influenza, purified antigen | J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BB Influenza vaccines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| BR | Câmara de Regulação do Mercado de Medicamentos | 500213040030713, 500215070034103, 500215070034203 |
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 20-MBE-0315 |
| EE | Ravimiamet | 1165418, 1165429 |
| HK | Department of Health Drug Office | 51268 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1017705, 1017706 |
| NL | Z-Index G-Standaard, PRK | 204706 |
| NZ | Medicines and Medical Devices Safety Authority | 11227 |
| PL | Rejestru Produktów Leczniczych | 100224699 |
| SG | Health Sciences Authority | 13177P |
| TN | Direction de la Pharmacie et du Médicament | 18243011 |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699820960117 |
| ZA | Health Products Regulatory Authority | T/30.1/581 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.